Skip to main content

Medical Cannabis Use for Chronic Pain Linked to New-Onset Arrhythmia

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 14, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Jan. 12, 2024 -- For patients with chronic pain, medical cannabis use is associated with an increased risk for new-onset arrhythmia, according to a study published online Jan. 11 in the European Heart Journal.

Anders Holt, M.D., from Copenhagen University Hospital -- Herlev and Gentofte in Denmark, and colleagues used nationwide Danish registers to examine the safety of prescribed medical cannabis in terms of cardiovascular side effects. Patients with chronic pain initiating first-time treatment with medical cannabis during 2018 to 2021 were matched to control patients on age, sex, chronic pain diagnosis, and concomitant use of other pain medications in a 1:5 ratio.

Of 1.88 million patients with chronic pain, 5,391 claimed a prescription of medical cannabis and were compared to 26,941 control patients. The researchers observed arrhythmia within 180 days in 42 and 107 individuals in the medical cannabis and control groups, respectively. Compared with no use, medical cannabis use was associated with an increased risk for new-onset arrhythmia (180-day absolute risk, 0.8 versus 0.4 percent; risk ratio, 2.07). There was no significant association seen for acute coronary syndrome.

"Despite the observational nature of these findings, any knowledge on cardiovascular risk following medical cannabis use is vital for any physician prescribing medical cannabis, a position more and more physicians will likely find themselves in," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Arrythmias Are a Significant Comorbidity in Adult Congenital Heart Disease

WEDNESDAY, April 17, 2024 -- For patients with adult congenital heart disease, arrythmias are a significant comorbidity and are associated with health care use and increased...

Factors Identified for Integrative Health and Medicine Use in Chronic Pain

MONDAY, Feb. 12, 2024 -- Factors associated with engagement in integrative health and medicine (IHM) and nonpharmacologic modalities versus opioids have been identified for adults...

2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults

WEDNESDAY, Feb. 7, 2024 -- Between 2002 and 2022, U.S. adults significantly increased use of complementary health approaches (CHAs), including for pain management, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.